Cargando…

The impact of ketogenic diet on the onset and progression of multiple sclerosis

Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system (CNS) characterized by inflammation and neurodegeneration. Current research suggests that diet may influence disease course, severity of symptoms, and quality of life in MS patients. The ketogenic diet (KD) has bee...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brockhoff, Jurij D., Bereswill, Stefan, Heimesaat, Markus M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Akadémiai Kiadó 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10578139/ https://www.ncbi.nlm.nih.gov/pubmed/37665667 http://dx.doi.org/10.1556/1886.2023.00020

Ejemplares similares

The Therapeutic Potential of the Ketogenic Diet in Treating Progressive Multiple Sclerosis
por: Storoni, Mithu, et al.
Publicado: (2015)

Ketogenic diets attenuate cyclooxygenase and lipoxygenase gene expression in multiple sclerosis
por: Bock, Markus, et al.
Publicado: (2018)

Exploring the impact of ketogenic diet on multiple sclerosis: obesity, anxiety, depression, and the glutamate system
por: Ortí, Jose Enrique de la Rubia, et al.
Publicado: (2023)

When is a Ketogenic Diet Ketogenic? Comment on “Satiating Effect of a Ketogenic Diet and Its Impact on Muscle Improvement and Oxidation State in Multiple Sclerosis Patients, Nutrients 2019, 11, 1156”
por: Klement, Rainer Johannes
Publicado: (2019)

Reduced Mass and Diversity of the Colonic Microbiome in Patients with Multiple Sclerosis and Their Improvement with Ketogenic Diet
por: Swidsinski, Alexander, et al.
Publicado: (2017)

Modulation of the intestinal microbiota impacts the efficacy of immunotherapy in cancer patients – A recent literature survey
por: Ziegler, Stella, et al.
Publicado: (2022)

Reply to “When Is a Ketogenic Diet Ketogenic? Comment on Satiating Effect of a Ketogenic Diet and Its Impact on Muscle Improvement and Oxidation State in Multiple Sclerosis Patients. Nutrients 2019, 11, 1156”
por: Benlloch, María, et al.
Publicado: (2019)

Ketogenic diet and fasting diet as Nutritional Approaches in Multiple Sclerosis (NAMS): protocol of a randomized controlled study
por: Bahr, Lina Samira, et al.
Publicado: (2020)

Satiating Effect of a Ketogenic Diet and Its Impact on Muscle Improvement and Oxidation State in Multiple Sclerosis Patients
por: Benlloch, María, et al.
Publicado: (2019)

Ketogenic and Modified Mediterranean Diet as a Tool to Counteract Neuroinflammation in Multiple Sclerosis: Nutritional Suggestions
por: Di Majo, Danila, et al.
Publicado: (2022)

Inflammation-Mediated Memory Dysfunction and Effects of a Ketogenic Diet in a Murine Model of Multiple Sclerosis
por: Kim, Do Young, et al.
Publicado: (2012)

Triple Therapy with Metformin, Ketogenic Diet, and Metronomic Cyclophosphamide Reduced Tumor Growth in MYCN-Amplified Neuroblastoma Xenografts
por: Catalano, Luca, et al.
Publicado: (2023)

Murine fecal microbiota transplantation lowers gastrointestinal pathogen loads and dampens pro-inflammatory immune responses in Campylobacter jejuni infected secondary abiotic mice
por: Heimesaat, Markus M., et al.
Publicado: (2019)

Antibacterial effects of biologically active ingredients in hop provide promising options to fight infections by pathogens including multi-drug resistant bacteria
por: Fahle, Anton, et al.
Publicado: (2022)

Editorial for “The Role of Ketogenic Diet in Human Health and Diseases”: The Multifaceted Impact of Ketogenic Diets on Health and Disease
por: Watanabe, Mikiko, et al.
Publicado: (2023)

Dissecting the Interplay Between Intestinal Microbiota and Host Immunity in Health and Disease: Lessons Learned from Germfree and Gnotobiotic Animal Models
por: Fiebiger, Ulrike, et al.
Publicado: (2016)

Fecal Microbiota Transplantation Decreases Intestinal Loads of Multi-Drug Resistant Pseudomonas aeruginosa in Murine Carriers
por: Mrazek, Katharina, et al.
Publicado: (2019)

Murine Fecal Microbiota Transplantation Alleviates Intestinal and Systemic Immune Responses in Campylobacter jejuni Infected Mice Harboring a Human Gut Microbiota
por: Heimesaat, Markus M., et al.
Publicado: (2019)

Antimicrobial and Immune-Modulatory Effects of Vitamin D Provide Promising Antibiotics-Independent Approaches to Tackle Bacterial Infections – Lessons Learnt from a Literature Survey
por: Golpour, Ainoosh, et al.
Publicado: (2019)

Immunomodulatory and Antimicrobial Effects of Vitamin C
por: Mousavi, Soraya, et al.
Publicado: (2019)

Novel Clinical Campylobacter jejuni Infection Models Based on Sensitization of Mice to Lipooligosaccharide, a Major Bacterial Factor Triggering Innate Immune Responses in Human Campylobacteriosis
por: Mousavi, Soraya, et al.
Publicado: (2020)

A literature survey on antimicrobial and immune-modulatory effects of butyrate revealing non-antibiotic approaches to tackle bacterial infections
por: DU, KE, et al.
Publicado: (2021)

Ketogenic Diet for the Management of Epilepsy Associated with Tuberous Sclerosis Complex in Children
por: Park, Soyoung, et al.
Publicado: (2017)

Antibacterial effects of vanilla ingredients provide novel treatment options for infections with multidrug-resistant bacteria – A recent literature review
por: Maisch, Noah A., et al.
Publicado: (2022)

Multidrug-Resistant Pseudomonas Aeruginosa Induce Systemic Pro-Inflammatory Immune Responses in Colonized Mice
por: von Klitzing, Eliane, et al.
Publicado: (2017)

Finding Novel Antibiotic Substances from Medicinal Plants – Antimicrobial Properties of Nigella Sativa Directed against Multidrug-resistant Bacteria
por: Bakal, Seher Nancy, et al.
Publicado: (2017)

Impact Of Ketogenic Diet On Athletes: Current Insights
por: McSwiney, Fionn T, et al.
Publicado: (2019)

Comprehensive Kinetic Survey of Intestinal, Extra-Intestinal and Systemic Sequelae of Murine Ileitis Following Peroral Low-Dose Toxoplasma gondii Infection
por: Heimesaat, Markus M., et al.
Publicado: (2019)

Ketogenic Diet and Epilepsy
por: Ułamek-Kozioł, Marzena, et al.
Publicado: (2019)

Progress in the Management of Paediatric-Onset Multiple Sclerosis
por: Luchesa Smith, Aphra, et al.
Publicado: (2020)

The Host-Specific Intestinal Microbiota Composition Impacts Campylobacter coli Infection in a Clinical Mouse Model of Campylobacteriosis
por: Heimesaat, Markus M., et al.
Publicado: (2020)

Not only for Christmas: Prophylactic oral application of trans-cinnamaldehyde alleviates acute murine campylobacteriosis
por: Heimesaat, Markus M., et al.
Publicado: (2023)

Ketogenic diets and physical performance
por: Phinney, Stephen D
Publicado: (2004)

Anti-Pathogenic and Immune-Modulatory Effects of Peroral Treatment with Cardamom Essential Oil in Acute Murine Campylobacteriosis
por: Heimesaat, Markus M., et al.
Publicado: (2021)

Preclinical Evaluation of Oral Urolithin-A for the Treatment of Acute Campylobacteriosis in Campylobacter jejuni Infected Microbiota-Depleted IL-10(−/−) Mice
por: Mousavi, Soraya, et al.
Publicado: (2020)

Disease-Alleviating Effects of Peroral Activated Charcoal Treatment in Acute Murine Campylobacteriosis
por: Bereswill, Stefan, et al.
Publicado: (2021)

Immune-Modulatory Effects upon Oral Application of Cumin-Essential-Oil to Mice Suffering from Acute Campylobacteriosis
por: Mousavi, Soraya, et al.
Publicado: (2021)

Garlic Essential Oil as Promising Option for the Treatment of Acute Campylobacteriosis—Results from a Preclinical Placebo-Controlled Intervention Study
por: Heimesaat, Markus M., et al.
Publicado: (2021)

Treatment with the Probiotic Product Aviguard(®) Alleviates Inflammatory Responses during Campylobacter jejuni-Induced Acute Enterocolitis in Mice
por: Heimesaat, Markus M., et al.
Publicado: (2021)

Campylobacter jejuni infection induces acute enterocolitis in IL-10(-/-) mice pretreated with ampicillin plus sulbactam
por: Heimesaat, Markus M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_22ui08k64jprgudr3kfbn00d5i